1.Correlation between Contrast-enhanced Ultrasound and Risk of Tumor Recurrence in Papillary Thyroid Carcinoma.
Wen LI ; Yan ZHANG ; Qing SONG ; Yu LAN ; Hong-Ying HE ; Jun MA ; Jia-Hang ZHAO ; Yi LI ; Yu-Kun LUO
Acta Academiae Medicinae Sinicae 2021;43(3):343-349
Objective To explore the association between contrast-enhanced ultrasound and risk of tumor recurrence in papillary thyroid carcinoma(PTC). Methods A total of 287 PTCs in 287 patients who underwent surgery,conventional ultrasound,and contrast-enhanced ultrasound(CEUS)were enrolled in this study.According to 2015 American Thyroid Association(ATA)Modified Initial Risk Stratification System,the patients were categorized into three groups:low risk,intermediate risk,and high risk.The CEUS patterns of PTCs were compared between different risk stratifications. Results Hypo-enhancement was presented in 57.6% of ATA low-risk PTCs,iso-enhancement in 62.3% of ATA intermediate-risk PTCs,and hyper-enhancement in 48.2% of ATA high-risk PTCs(
Humans
;
Neoplasm Recurrence, Local/diagnostic imaging*
;
Thyroid Cancer, Papillary/diagnostic imaging*
;
Thyroid Neoplasms/diagnostic imaging*
;
Ultrasonography
2.Application of molecular probes in nuclear imaging of neuroendocrine tumors.
Jing YAN ; Tingting ZHANG ; Kui ZHAO
Journal of Zhejiang University. Medical sciences 2021;50(1):131-137
Neuroendocrine tumors are a type of heterogeneous tumors originating from neuroendocrine cells derived from the neural crest,which can secrete a variety of amines and peptide hormones.Based on different molecular biomarkers,histologic types and differentiation degrees,individualized nuclear imaging can provide information for the early diagnosis,clinical staging,treatment guidance,and detection of the recurrence and metastasis of neuroendocrine tumor. In this paper,we review the development and application of nuclear medicine molecular imaging probes such as glucose analogs,somatostatin analogues,amine precursors,hormone analogs and enzyme inhibitors in the diagnosis and treatment of neuroendocrine tumors.
Diagnostic Imaging
;
Humans
;
Molecular Probes
;
Neoplasm Recurrence, Local
;
Neuroendocrine Tumors/diagnostic imaging*
;
Radionuclide Imaging
3.Diagnostic accuracy of dynamic contrast-enhanced magnetic resonance imaging for distinguishing pseudoprogression from glioma recurrence: a meta-analysis.
Jun QIU ; Zhen-Chao TAO ; Ke-Xue DENG ; Peng WANG ; Chuan-Yu CHEN ; Fang XIAO ; Yi LUO ; Shu-Ya YUAN ; Hao CHEN ; Huan HUANG
Chinese Medical Journal 2021;134(21):2535-2543
BACKGROUND:
It is crucial to differentiate accurately glioma recurrence and pseudoprogression which have entirely different prognosis and require different treatment strategies. This study aimed to assess the diagnostic accuracy of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a tool for distinguishing glioma recurrence and pseudoprogression.
METHODS:
According to particular criteria of inclusion and exclusion, related studies up to May 1, 2019, were thoroughly searched from several databases including PubMed, Embase, Cochrane Library, and Chinese biomedical databases. The quality assessment of diagnostic accuracy studies was applied to evaluate the quality of the included studies. By using the "mada" package in R, the heterogeneity, overall sensitivity, specificity, and diagnostic odds ratio were calculated. Moreover, funnel plots were used to visualize and estimate the publication bias in this study. The area under the summary receiver operating characteristic (SROC) curve was computed to display the diagnostic efficiency of DCE-MRI.
RESULTS:
In the present meta-analysis, a total of 11 studies covering 616 patients were included. The results showed that the pooled sensitivity, specificity, and diagnostic odds ratio were 0.792 (95% confidence interval [CI] 0.707-0.857), 0.779 (95% CI 0.715-0.832), and 16.219 (97.5% CI 9.123-28.833), respectively. The value of the area under the SROC curve was 0.846. In addition, the SROC curve showed high sensitivities (>0.6) and low false positive rates (<0.5) from most of the included studies, which suggest that the results of our study were reliable. Furthermore, the funnel plot suggested the existence of publication bias.
CONCLUSIONS
While the DCE-MRI is not the perfect diagnostic tool for distinguishing glioma recurrence and pseudoprogression, it was capable of improving diagnostic accuracy. Hence, further investigations combining DCE-MRI with other imaging modalities are required to establish an efficient diagnostic method for glioma patients.
Glioma/diagnostic imaging*
;
Humans
;
Magnetic Resonance Imaging
;
Neoplasm Recurrence, Local/diagnostic imaging*
;
ROC Curve
;
Sensitivity and Specificity
4.Lhermitte-Duclos disease: A case report and literature review.
Zhiqiang LIU ; Yanqing HE ; Jiaxin FU ; Jun WU ; Tao SONG ; Ying WANG ; Tianxiang HUANG
Journal of Central South University(Medical Sciences) 2021;46(2):195-199
Lhermitte-Duclos disease (LDD) is a type of rare brain tumor located in posterior fossa. A patient with LDD located in the left cerebellum and vermis was admitted by the Department of Neurosurgery, Xiangya Hospital, Central South University. MRI scan showed slightly heterogeneous enhancement at the region close to vermis. The patient underwent partial resection on August 11, 2016 without postoperative chemoradiotherapy. The progress free survival was 11 months and the overall survival was 17 months. What the case reveals is that the partial resection is not beneficial to these patients with LDD as the residual lesion probably recurs in a short term after operation. The pathogenesis, diagnosis and treatment of LDD are explored and summarized in combination with relevant literature.
Cerebellar Neoplasms/surgery*
;
Cerebellum
;
Hamartoma Syndrome, Multiple/diagnostic imaging*
;
Humans
;
Magnetic Resonance Imaging
;
Neoplasm Recurrence, Local
6.Current status of 18F-FDG PET in predicting outcome of cancer therapy.
Chinese Journal of Oncology 2004;26(10):577-580
Breast Neoplasms
;
diagnostic imaging
;
Carcinoma, Non-Small-Cell Lung
;
diagnostic imaging
;
pathology
;
therapy
;
Fluorodeoxyglucose F18
;
Humans
;
Lung Neoplasms
;
diagnostic imaging
;
pathology
;
therapy
;
Lymphoma
;
diagnostic imaging
;
Neoplasm Recurrence, Local
;
diagnostic imaging
;
Neoplasm Staging
;
Neoplasm, Residual
;
Positron-Emission Tomography
;
Treatment Outcome
7.(18)F-FDG PET/CT for extranodular natural killer/T-cell lymphoma nasal type: imaging findings and clinical value.
Jian-Hua SONG ; Wen-Li QIAO ; Xiang CHEN ; Chang-Cun LIU ; Yan XING ; Tai-Song WANG ; Jin-Hua ZHAO
Journal of Southern Medical University 2016;36(8):1123-1128
OBJECTIVETo explore the value of (18)F-FDG PET/CT in the diagnosis and treatment evaluation in patients with pretreatment or recurrent extranodular natural killer/T-cell lymphoma nasal type (ENTCL).
METHODS(18)F-FDG PET/CT images and clinical records of 35 cases (67 scans) of pathologically confirmed ENTCL treated in our hospital within the last 9 years were analyzed. The imaging characteristics of the upper aerodigestive tract (UAT) and the non-aerodigestive tract (NUAT) lesions were analyzed. Lesion distribution, clinical stages, SUVmax and patient survival data were compared between pretreatment and recurrent cases.
RESULTSs All the ENTCL lesions were hypermetabolic. The UAT lesions involved mainly the nasal cavity and pharynx, while the NUAT lesions may involve the lymph nodes and all the organs. UAT lesions were more common in pretreatment cases while NUAT lesions tended to increase in recurrent cases. The SUVmax of pretreatment and recurrent lesions were 10.4∓4.4 and 9.6∓5.2, and showed no significant difference among patients with different lesion distribution patterns, clinical stages, or treatment history. The tumor remission rate evaluated by PET/CT were higher in cases with an initial diagnosis than in those with recurrence [(89.5% (17/19) vs 33.3% (5/15), P<0.005)]. Cox regression analysis revealed no significant differences in the survival rates among patients with different treatment history, clinical stages, lesion distribution patterns, or SUVmax levels (P>0.05).
CONCLUSION(18)F-FDG PET/CT can sensitively detect the pretreatment or recurrent lesions in ENTCL patients and helps in accurate tumor staging and curative effect evaluation.
Fluorodeoxyglucose F18 ; Humans ; Lymphoma, Extranodal NK-T-Cell ; diagnostic imaging ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Positron Emission Tomography Computed Tomography
8.Liver transplantation for advanced hepatocellular carcinoma.
Clinical and Molecular Hepatology 2016;22(3):309-318
There has been ongoing debate that the Milan criteria may be too strict that a significant number of patients who could benefit from liver transplantation (LT) might have been excluded. Based on this idea, various studies have been conducted to further expand the Milan criteria and give more HCC patients a chance of cure. In deceased donor LT (DDLT) setting, expansion of the criteria is relatively tempered because the results of LT for HCC should be comparable to those of patients with non-malignant indications. On the other hand, in living donor LT (LDLT) situation, liver grafts are not public resources. The acceptable target outcomes for LDLT might be much lower than those for DDLT. Patients with biologically favorable tumors might have excellent survivals after LT despite morphological advanced HCCs. Therefore, the significance and utility of biological tumor parameters for selecting suitable LT candidates have been increased to predict HCC recurrence after LT. Although there is no consensus regarding the use of prognostic biomarkers in LT selection criteria for HCC, the combination of conventional morphological parameters and new promising biomarkers could help us refine and expand the LT criteria for HCC in the near future.
Biomarkers, Tumor/analysis
;
Carcinoma, Hepatocellular/diagnostic imaging/pathology/*therapy
;
Humans
;
Liver Neoplasms/diagnostic imaging/pathology/*therapy
;
Liver Transplantation
;
Neoplasm Recurrence, Local
;
Neoplasm Staging
;
Patient Selection
;
Positron-Emission Tomography
9.Salvage surgical approach for patients with post-radiation local recurrent nasopharyngeal carcinoma.
Yue-jian WANG ; Wei-xiong CHEN ; Zhao-feng ZHU ; Feng-ping LI
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2005;40(11):810-813
OBJECTIVETo evaluate salvage surgical approaches and efficacy for post-radiation local recurrent nasopharyngeal carcinoma (NPC).
METHODSThirteen patients with post-radiation local recurrent NPC underwent salvage surgical treatment by routes as transpalatal approach, nasal medial swing approach, maxillary swing approach and infratemporal fossa approach. All cases were followed up for 2 to 5 years. Analysis was done on the indications and efficacy of these 4 different approaching routes.
RESULTSNo immediate operative complications occurred for all these 13 cases. Four patients with T1 and T2a operated via transpalatal approach and nasal medial swing approach survived more than 3 years. Five patients with T2b and T3 operated via maxillary swing approach. Among them, two patients died at second and 24th month after operation, one survived with tumor and died at 13rd month after operation, two were alive free of tumor for 2 and 4 years after operation. Four patients with T4 operated via infratemporal fossa approach. Among them, three died in 1 year, one was alive free of tumor for 2 years.
CONCLUSIONSSurgical approaches were decided by a comprehensive consideration of recurrent tumor site and invasive range to achieve the best operative site exposure with minimal traumatic damage.
Adult ; Female ; Humans ; Male ; Middle Aged ; Nasopharyngeal Neoplasms ; diagnostic imaging ; pathology ; Neoplasm Recurrence, Local ; surgery ; Radiography ; Salvage Therapy
10.PET/CT imaging manifestations of different pathological subtypes of liposarcoma.
Jianlan FU ; Fahuan SONG ; Aiping CHENG
Journal of Zhejiang University. Medical sciences 2019;48(2):193-199
OBJECTIVE:
To analyze PET/CT imaging manifestations of different pathological subtypes of liposarcoma.
METHODS:
The F-fluorodeoxyglucose(FDG) PET/CT features of 13 patients pathologically confirmed as liposarcoma were retrospectively reviewed. The metabolism degree and distribution of different subtypes of liposarcoma were compared.
RESULTS:
The well-differentiated liposarcoma showed fat density mass with septa and irregular strip with mild FDG uptake. The myxoid liposarcoma showed cystic or cystic solid mass, single or multiple with mild-moderate FDG uptake heterogeneously or homogeneously. The dedifferentiated liposarcoma showed mixed soft tissue mass with high FDG uptake heterogeneously, larger lesion with necrosis centrally. The mixed type contained well differentiated type and dedifferentiated type, and showed multiple lesion with combined imaging manifestations. There were local invasions in 12 cases, no lymph node matastasis, and the recurrence of dedifferentiated liposarcoma with lung metastasis in 1 case. The maximum standard values (SUVmax) of FNCCLE grade G1, G2 and G3 liposarcoma were 3.00, 5.67 and 10.33, respectively; there was significant difference between G1 and G3 groups, G2 and G3 groups (all <0.05).
CONCLUSIONS
PET/CT manifestations of liposarcoma of various pathological subtypes are different. Preoperative PET/CT examination can clarify the pathological types, scope of tumor invasion and metastasis of liposarcoma, which provides more information for clinical decision-making and is helpful for the preparation of surgical plan.
Humans
;
Liposarcoma
;
classification
;
diagnostic imaging
;
pathology
;
Neoplasm Recurrence, Local
;
Positron Emission Tomography Computed Tomography
;
Retrospective Studies
;
Tomography, X-Ray Computed